Reframe Cancer joins GRiD

Driving awareness of cancer support

Jaskeet Briah
clock • 1 min read

Reframe Cancer has been named as a new member of industry body, Group Risk Development (GRiD), to drive knowledge and awareness of cancer support.

Reframe Cancer offers cancer navigation and whole of workplace care for employers and employees impacted by cancer. The cancer support provider works directly with employers and partners with insurers to deliver a personalised service to their customers affected by the disease. Cancer was once again the main cause of claims across all three types of group risk product last year, according to GRiD. The illness accounted for 68% of group critical illness claims, 39% of group life claims and 24% of group income protection claims. Mark Stephenson, chief executive officer, Reframe Cance...

To continue reading this article...

Join COVER for free

  • Unlimited access to real-time news, key trend analysis and industry insights.
  • Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
  • Receive breaking news stories straight to your inbox in the daily newsletter.
  • Members only access to monthly programme 'The COVER Review'
  • Be the first to hear about our CPD accredited events and awards programmes.

Join now

 

Already a Cover member?

Login

More on PMI

National Friendly launches healthcare product
PMI

National Friendly launches healthcare product

No medical questions or underwriting

Jaskeet Briah
clock 14 October 2025 • 2 min read
PMI claims up 6% as mental health treatments increase
PMI

PMI claims up 6% as mental health treatments increase

Drop in claims cost for cancer treatments

Jaskeet Briah
clock 13 October 2025 • 3 min read
27% of Brits self-funded private treatment in last five years: Howden
PMI

27% of Brits self-funded private treatment in last five years: Howden

Average treatment cost £6,000

Cameron Roberts
clock 02 October 2025 • 2 min read